155 related articles for article (PubMed ID: 32038241)
21. Rosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation.
Jin BR; Chung KS; Cheon SY; Lee M; Hwang S; Noh Hwang S; Rhee KJ; An HJ
Sci Rep; 2017 Apr; 7():46252. PubMed ID: 28383063
[TBL] [Abstract][Full Text] [Related]
22. Boldine suppresses dextran sulfate sodium-induced mouse experimental colitis: NF-κB and IL-6/STAT3 as potential targets.
Pandurangan AK; Mohebali N; Hasanpourghadi M; Looi CY; Mustafa MR; Mohd Esa N
Biofactors; 2016 May; 42(3):247-58. PubMed ID: 26891685
[TBL] [Abstract][Full Text] [Related]
23. Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis.
Zhang H; Zhang Z; Song G; Tang X; Song H; Deng A; Wang W; Wu L; Qin H
Eur J Pharm Sci; 2017 Nov; 109():56-64. PubMed ID: 28757346
[TBL] [Abstract][Full Text] [Related]
24. Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis.
Trivedi PP; Jena GB
Food Chem Toxicol; 2013 Sep; 59():339-55. PubMed ID: 23793040
[TBL] [Abstract][Full Text] [Related]
25. Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway.
Li L; Shen A; Chu J; Sferra TJ; Sankararaman S; Ke X; Chen Y; Peng J
Mol Med Rep; 2018 Jul; 18(1):1113-1119. PubMed ID: 29845215
[TBL] [Abstract][Full Text] [Related]
26. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis.
Liu Y; Liu X; Hua W; Wei Q; Fang X; Zhao Z; Ge C; Liu C; Chen C; Tao Y; Zhu Y
Int Immunopharmacol; 2018 Apr; 57():121-131. PubMed ID: 29482156
[TBL] [Abstract][Full Text] [Related]
27. Resatorvid (TAK-242) Ameliorates Ulcerative Colitis by Modulating Macrophage Polarization and T Helper Cell Balance via TLR4/JAK2/STAT3 Signaling Pathway.
Huang X; Lin R; Liu H; Dai M; Guo J; Hui W; Liu W; Haerken M; Zheng R; Yushanjiang T; Gao F
Inflammation; 2024 May; ():. PubMed ID: 38760646
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammation of Erianin in dextran sulphate sodium-induced ulcerative colitis mice model via collaborative regulation of TLR4 and STAT3.
Dou B; Hu W; Song M; Lee RJ; Zhang X; Wang D
Chem Biol Interact; 2020 Jun; 324():109089. PubMed ID: 32272095
[TBL] [Abstract][Full Text] [Related]
29. Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Involvement of NF-κB and MAPK signalling pathways.
Gao Z; Yu C; Liang H; Wang X; Liu Y; Li X; Ji K; Xu H; Yang M; Liu K; Qi D; Fan H
Int Immunopharmacol; 2018 Apr; 57():82-90. PubMed ID: 29475099
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.
Zhang ZL; Fan HY; Yang MY; Zhang ZK; Liu K
World J Gastroenterol; 2014 Nov; 20(41):15310-8. PubMed ID: 25386079
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
Zhu L; Gu P; Shen H
Int Immunopharmacol; 2019 Mar; 68():242-251. PubMed ID: 30743078
[TBL] [Abstract][Full Text] [Related]
32. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
[TBL] [Abstract][Full Text] [Related]
33. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.
Yan YX; Shao MJ; Qi Q; Xu YS; Yang XQ; Zhu FH; He SJ; He PL; Feng CL; Wu YW; Li H; Tang W; Zuo JP
Acta Pharmacol Sin; 2018 Oct; 39(10):1633-1644. PubMed ID: 29849131
[TBL] [Abstract][Full Text] [Related]
34. α-Mangostin ameliorates dextran sulfate sodium-induced colitis through inhibition of NF-κB and MAPK pathways.
You BH; Chae HS; Song J; Ko HW; Chin YW; Choi YH
Int Immunopharmacol; 2017 Aug; 49():212-221. PubMed ID: 28601023
[TBL] [Abstract][Full Text] [Related]
35. Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice.
Cui Y; Wei H; Lu F; Liu X; Liu D; Gu L; Ouyang C
PLoS One; 2016; 11(2):e0148241. PubMed ID: 26840426
[TBL] [Abstract][Full Text] [Related]
36. Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes.
Cao Q; Gao X; Lin Y; Yue C; Wang Y; Quan F; Zhang Z; Liu X; Lu Y; Zhan Y; Yang H; Li X; Qin D; Birnbaumer L; Hao K; Yang Y
Theranostics; 2019; 9(25):7490-7505. PubMed ID: 31695782
[No Abstract] [Full Text] [Related]
37. Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance.
Xu M; Duan XY; Chen QY; Fan H; Hong ZC; Deng SJ; Nan Z; Wu H; Dong YL; Liu YJ; Zhou CZ
Biomed Pharmacother; 2019 Jan; 109():2396-2408. PubMed ID: 30551499
[TBL] [Abstract][Full Text] [Related]
38. Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis.
Marín M; María Giner R; Ríos JL; Recio MC
J Ethnopharmacol; 2013 Dec; 150(3):925-34. PubMed ID: 24140585
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
40. Screening of the optimized prescription from Suqingwan in terms of its therapeutic effect on DSS-induced ulcerative colitis by its regulation of inflammatory and oxidative mediators.
Shao J; Liu Z; Wang L; Song Z; Chang H; Han N; Yin J
J Ethnopharmacol; 2017 Apr; 202():54-62. PubMed ID: 28284792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
